A2 Vertaisarvioitu katsausartikkeli tieteellisessä lehdessä
Application of Human Induced Pluripotent Stem Cell Technology for Cardiovascular Regenerative Pharmacology
Tekijät: Majid Q, Orsolits B, Pohjolainen L, Kovacs Z, Kovács Z, Földes G, Talman V
Toimittaja: Nagy A, Turksen K
Kustantaja: Humana press
Julkaisuvuosi: 2022
Kokoomateoksen nimi: Induced Pluripotent Stem (iPS) Cells
Sarjan nimi: Methods in Molecular Biology
ISBN: 978-1-0716-2121-9
DOI: https://doi.org/10.1007/7651_2021_369
Verkko-osoite: https://researchportal.helsinki.fi/en/publications/d29e2e60-beb8-4074-9485-29680abb24b0
Tiivistelmä
Cardiovascular diseases are one of the leading causes of mortality in the western world. Myocardial infarction is among the most prevalent and results in significant cell loss within the myocardium. Similarly, numerous drugs have been identified as having cardiotoxic side effects. The adult human heart is however unable to instigate an effective repair mechanism and regenerate the myocardium in response to such damage. This is in large part due to the withdrawal of cardiomyocytes (CMs) from the cell cycle. Thus, identifying, screening, and developing agents that could enhance the proliferative capacity of CMs holds great potential in cardiac regeneration. Human induced pluripotent stem cells (hiPSCs) and their cardiovascular derivatives are excellent tools in the search for such agents. This chapter outlines state-of-the art techniques for the two-dimensional differentiation and attainment of hiPSC-derived CMs and endothelial cells (ECs). Bioreactor systems and three-dimensional spheroids derived from hiPSC-cardiovascular derivatives are explored as platforms for drug discovery before focusing on relevant assays that can be employed to assess cell proliferation and viability.
Cardiovascular diseases are one of the leading causes of mortality in the western world. Myocardial infarction is among the most prevalent and results in significant cell loss within the myocardium. Similarly, numerous drugs have been identified as having cardiotoxic side effects. The adult human heart is however unable to instigate an effective repair mechanism and regenerate the myocardium in response to such damage. This is in large part due to the withdrawal of cardiomyocytes (CMs) from the cell cycle. Thus, identifying, screening, and developing agents that could enhance the proliferative capacity of CMs holds great potential in cardiac regeneration. Human induced pluripotent stem cells (hiPSCs) and their cardiovascular derivatives are excellent tools in the search for such agents. This chapter outlines state-of-the art techniques for the two-dimensional differentiation and attainment of hiPSC-derived CMs and endothelial cells (ECs). Bioreactor systems and three-dimensional spheroids derived from hiPSC-cardiovascular derivatives are explored as platforms for drug discovery before focusing on relevant assays that can be employed to assess cell proliferation and viability.
Turun yliopiston Tutkimustietojärjestelmän portaali